Development of NIR‐II Ratiometric Fluorescent Nanoprobe for HClO Imaging in Acute Lung Injury
Advanced Healthcare Materials · 2025
DOI: 10.1002/adhm.202402264 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Fei-Yu Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering, Hunan University, Changsha, 410082, P. R. C…. Hauptthemen laut MEDLINE: Acute Lung Injury, Fluorescent Dyes, Hypochlorous Acid, Nanoparticles. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Natural Science Foundation of Hunan Province, Fundamental Research Funds for the Central Universities, Advanced Talents Incubation Program of Hebei University.
Abstract (Originalsprache)
Efficient and high‐contrast bioimaging of acute lung injury (ALI) is crucial for studying disease progression and enabling timely interventional treatments. However, developing bioimaging probes in the second near‐infrared (NIR‐II) window to assess ALI remains challenging. In particular, ratiometric NIR‐II probes with self‐calibration functions are rare, hindering reliable detection of information during the ALI process. Herein, through hypochlorous acid (HClO) detection, a novel lung‐targeting NIR‐II ratiometric fluorescent nanoprobe (LNRFN) is developed for in vivo ALI assessment. Specifically, LNRFN integrates the NIR‐II fluorophore RT4‐C5, which responds to HClO, and the insensitive fluorophore DAD‐LZ, which serves as an internal reference, encapsulated in polystyrene‐co‐maleic anhydride (PSMA). Photophysical property studies showed that LNRFN exhibits maximum emission wavelengths above 1000 nm under 808 and 980 nm excitation. In the presence of HClO, the maximum emission at 1018 nm, when excited at 980 nm, is rapidly quenched, whereas the emission upon 808 nm excitation remains stable. Thanks to the ratiometric signal, LNRFN reliably detected endogenous HClO in both paw edema models and cell experiments. Additionally, LNRFN effectively assessed the ALI progression by monitoring HClO levels in the NIR‐II window, benefiting from its excellent lung‐targeting ability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering, Hunan University, Changsha, 410082, P. R. China.
- Key Laboratory of Medicinal Chemistry and Molecular Diagnosis of the Ministry of Education, College of Chemistry and Materials Science, Hebei University, Baoding, 071002, P. R. China.
ORCID-Profile: Tian-Bing Ren
Förderung
- Natural Science Foundation of Hunan Province
- Fundamental Research Funds for the Central Universities
- Advanced Talents Incubation Program of Hebei University
- Interdisciplinary Project of Hebei University
- National Natural Science Foundation of China
Zitieren
APA
Yang, F. Y., Wang, J., Fan, X. P., Li, Z., Zhang, X. X., Liang, P. Z., Ren, T. B., Yuan, L., & Zhang, X. B. (2025). Development of NIR‐II Ratiometric Fluorescent Nanoprobe for HClO Imaging in Acute Lung Injury. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202402264
Vancouver
Yang FY, Wang J, Fan XP, Li Z, Zhang XX, Liang PZ, et al. Development of NIR‐II Ratiometric Fluorescent Nanoprobe for HClO Imaging in Acute Lung Injury. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202402264
BibTeX
@article{Yang2025,
author = {Yang, Fei-Yu and Wang, Jie and Fan, Xiao-Peng and Li, Zhe and Zhang, Xing-Xing and Liang, Ping-Zhao and Ren, Tian-Bing and Yuan, Lin and Zhang, Xiao-Bing},
title = {Development of NIR‐II Ratiometric Fluorescent Nanoprobe for HClO Imaging in Acute Lung Injury},
journal = {Advanced Healthcare Materials},
year = {2025},
doi = {10.1002/adhm.202402264}
}
EUVIMED